title: [Analysis for 13 term deliveries after cardiac valve replacement and percutaneous transluminal mitral commissuroplasty].
abstract: OBJECTIVE
  To study the cardiac function, mode of delivery and anticoagulant therapy in 13 pregnant women after cardiac valves replacement (CVR) and percutaneous transluminal mitral commissuroplasty (PTMC).
  
  
  METHODS
  Retrospective data analysis.
  
  
  RESULTS
  Patients with cardiac function of degree I to III can accomplish pregnancy and delivery safely after cardiac operation one and a half years. Using warfarin during pregnancy and delivery safely. Using warfarin during pregnancy and heparin during delivery did not increase the blood loss in both mothers and neonates, and congenital malformation either. It is more appropriate for pregnant women who had CVR to deliver by cesarean section and those who had PTMC to deliver vaginally.
  
  
  CONCLUSIONS
  Women after cardiac operation can accomplish pregnancy and delivery if their cardiac function belong to degree I-III with or without digoxin treatment before delivery. Using anticoagulant therapy correctly according to prothrombin time (PT) test during pregnancy does not increase delivery complications to both mothers and neonates.
authors: Beijing Anzhen Hospital.
authors: Y
authors: Y
authors: Wang
authors: J
authors: J
authors: Hu
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002404:Catheterization; D002585:Cesarean Section; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008943:Mitral Valve / Q000601:surgery; D008946:Mitral Valve Stenosis / Q000628:therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D012189:Retrospective Studies; D012214:Rheumatic Heart Disease / Q000628:therapy; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin